Funding for this research was provided by:
Received: 14 July 2020
Accepted: 8 February 2021
First Online: 16 February 2021
Ethics approval and consent to participate
: This study was IRB approved by Advarra and consent was received from all subjects for participation in this study. The study strictly adhered to the Health Insurance Portability and Accountability Act and all of the tenants of the Declaration of Helsinki. Finally, this study was registered and approved by the Food and Drug Administration under the identification number NCT02357342.
: Consent has been obtained for use of all subject images as a part of the institutional consent for this study.
: Each author’s conflict of interests both financial and nonfinancial are enumerated below:Robert Minturn, Peter Bracha, Maggie Klein, Ashley M Harless: None.Jay Chhablani: Research support through Allergan, Novartis, OD-OS.Raj K Maturi: Research support through Allergan, Allegro, GlaxoSmithKline, Genentech and Santen. Consulting agreement with Santen.